Your session is about to expire
← Back to Search
Extended Flushing Interval for Implanted Port Device Maintenance
N/A
Recruiting
Led By Bret Friday, MD, PhD
Research Sponsored by Essentia Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
No Deep Vein Thrombosis or significant Implanted Port Device complication within ≤ 4 weeks of registration.
Hematology/Oncology patients ≥ 18 years old with an Implanted Port Device
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 48 weeks post randomization
Awards & highlights
Study Summary
This trial is testing whether it's safe to extend the time between flushes for a type of cancer treatment.
Who is the study for?
This trial is for adult hematology/oncology patients with an implanted port device (IPD) used for chemotherapy, who haven't had complications like Deep Vein Thrombosis in the last 4 weeks. Participants should not need to use their IPD outside of routine flushing for the next 12 weeks and must be able to give informed consent and understand English.Check my eligibility
What is being tested?
The study is testing if it's safe to extend the routine flushing of implanted port devices from every 4 weeks to every 12 weeks. This could potentially make maintenance easier without compromising safety or effectiveness.See study design
What are the potential side effects?
Since this trial involves a change in maintenance schedule rather than medication, side effects are not expected as part of the intervention being tested.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I haven't had a serious blood clot or major issues with an implanted port in the last 4 weeks.
Select...
I am 18 or older with a port device implanted for cancer treatment.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 48 weeks post randomization
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 48 weeks post randomization
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Rate of IPD patency
Secondary outcome measures
Change in Participant Quality of Life and Satisfaction in Scheduled 4-week versus 12 week IPD flushes
Difference in complication rates in scheduled 4-week versus 12-week IPD flushes at 12, 24,36 and 48 weeks post randomization.
Difference in healthcare and patient cost in scheduled 4-week versus 12-week IPD flushes
+2 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: 12-week IPD Flushing ScheduleExperimental Treatment1 Intervention
IPD standard maintenance flushes and port assessments every 12 weeks.
Group II: 4-week IPD Flushing ScheduleActive Control1 Intervention
IPD standard maintenance flushes and port assessments every 4 weeks.
Find a Location
Who is running the clinical trial?
Minnesota Cancer Clinical Trials NetworkUNKNOWN
Essentia HealthLead Sponsor
26 Previous Clinical Trials
107,810 Total Patients Enrolled
Bret Friday, MD, PhDPrincipal InvestigatorEssentia Health
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I haven't had a serious blood clot or major issues with an implanted port in the last 4 weeks.I haven't had a serious blood clot or major issues with an implanted port in the last 4 weeks.You are allergic to heparin.You have a port device in your body and there's been no blood return from it for the past 14 days.I don't need to use my implanted port for anything other than flushing in the next 12 weeks.I am 18 or older with a port device implanted for cancer treatment.
Research Study Groups:
This trial has the following groups:- Group 1: 4-week IPD Flushing Schedule
- Group 2: 12-week IPD Flushing Schedule
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Maintenance of Implanted Port Devices Patient Testimony for trial: Trial Name: NCT05454189 — N/A
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is enrollment still open for this research venture?
"As per clinicaltrials.gov, this medical research program is not currently admitting participants; its initial posting was on August 1st 2022 and it was most recently updated on July 8th 2022. Nevertheless, there are 5 other studies that require volunteers right now."
Answered by AI
Who else is applying?
What state do they live in?
Minnesota
What site did they apply to?
Essentia Health St. Joseph's Medical Center
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
0
Why did patients apply to this trial?
I don’t have anything wrong with me, just wondering if you needed to test the drug on a healthy patient, I’d be happy to volunteer. Apologies if I wasted your time.
PatientReceived no prior treatments
Recent research and studies
Share this study with friends
Copy Link
Messenger